M. Ray

发表

Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy

H. Sandler, D. Hamstra, C. Pan, 2012, Radiation Oncology.

Cochlear Implantation with Ipsilateral Petroclival Chondrosarcoma

S. Telian, M. Ray, E. Lin, 2006, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

Radiation therapy for aggressive fibromatosis (desmoid tumor).

T. Lawrence, M. Ray, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary versus radiation‐associated craniofacial osteosarcoma

Dafydd G. Thomas, J. Herman, J. Mchugh, 2006, Cancer.

Targeted and systemic radiotherapy in the treatment of bone metastasis

M. Ray, Alexander Lin, A. Lin, 2007, Cancer and Metastasis Reviews.

Impact of common iliac nodal treatment on radiation outcomes in localized prostate cancer.

H. Sandler, P. McLaughlin, M. Schipper, 2008, Urology.

Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vasculature

James D. Murphy, D. Hamstra, S. Markwart, 2007, Clinical Cancer Research.

No effect of statins on biochemical outcomes after radiotherapy for localized prostate cancer.

H. Sandler, S. Daignault, M. Ray, 2009, Urology.

Percent positive biopsy cores as a prognostic factor for prostate cancer treated with external beam radiation.

R. Shah, H. Sandler, C. Pan, 2007, Urology.

Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer.

A. Chinnaiyan, K. M. Woods Ignatoski, S. Markwart, 2008, International journal of radiation oncology, biology, physics.

Genomic and Expression Analysis of the 8p11–12 Amplicon in Human Breast Cancer Cell Lines

Donna Albertson, D. Albertson, S. Ethier, 2004, Cancer Research.

Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer.

Judith Abrams, J. Abrams, S. Ethier, 2006, Cancer research.

Human Breast Cancer Multiple Interacting Oncogenes on the 8 p 11p 12 Amplicon in Updated

J. Abrams, S. Ethier, M. Ray, 2006 .

Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer.

Edgar Ben-Josef, Theodore S Lawrence, K. Griffith, 2007, International journal of radiation oncology, biology, physics.

Gemcitabine-mediated radiosensitization of human soft tissue sarcoma.

James D. Murphy, D. Hamstra, D. Lucas, 2008, Translational oncology.

Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostate.

R. Shah, K. Cooney, N. Goldstein, 2006, Urology.

Risk Factors for Local Recurrence and Metastasis in Soft Tissue Sarcomas of the Extremity

K. Griffith, F. Feng, M. Feng, 2012, American journal of clinical oncology.

E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes.

R. Shah, R. Mehra, H. Sandler, 2006, The Journal of urology.

Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma.

V. Sondak, K. Griffith, James D. Murphy, 2007, International journal of radiation oncology, biology, physics.

A Single Institution Experience using IMRT and IGRT for Adjuvant Loco-regional Radiotherapy in Breast Cancer Patients

M. Ray, R. Kingsley, D. Parnell, 2008 .

A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy

K. Pienta, S. Jolly, K. Cooney, 2015, Advances in radiation oncology.

Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.

E. Gillanders, K. Cooney, E. Lange, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis.

D. Kuban, M. Zelefsky, A. Zietman, 2004, International journal of radiation oncology, biology, physics.

Adjuvant therapy for soft tissue sarcoma.

S. Schuetze, M. Ray, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

Family history of prostate cancer and relapse after definitive external beam radiation therapy.

K. Cooney, R. Dunn, H. Sandler, 2003, International journal of radiation oncology, biology, physics.

Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure.

D. Kuban, M. Zelefsky, A. Zietman, 2006, Urology.

Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trial.

H. Sandler, K. Bae, W. Shipley, 2009, Journal of the National Cancer Institute.

Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy

H. Sandler, D. Hamstra, C. Pan, 2012, Radiation oncology.